Showing results (2841-2850 of 9,335) with videos related to

Sort By:
Pageof 934
Cancer Medicine|July 16, 2019
Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapyAtsushi Watanabe, Takeshi Inukai, Keiko Kagami, et al.
Cancer Medicine|July 18, 2019
Clinical conditions and treatment requirements for long-term survival among hepatitis B-related hepatocellular carcinoma initially treated with chemoembolizationZhen-Xin Chen, Zhi-Wei Jian, Xi-Wen Wu, et al.
Cancer Medicine|July 14, 2019
Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRIKatrina M Ingley, Sally M Burtenshaw, Nicole C Theobalds, et al.
Cancer Medicine|July 13, 2019
Rational application of the first-line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta-analysisRui Cao, Jie-Tao Ma, Shu-Ling Zhang, et al.
Cancer Medicine|July 13, 2019
miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4Li Wang, Kunkun Li, Chen Wang, et al.
Cancer Medicine|August 31, 2022
Co-amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of gliomaHaiwei Wang, Xinrui Wang, Liangpu Xu, et al.
Cancer Medicine|October 25, 2022
Clustering on longitudinal quality-of-life measurements using growth mixture models for clinical prognosis: Implementation on CCTG/AGITG CO.20 trialJiahui Zhang, Weili Kong, Pingzhao Hu, et al.
Cancer Medicine|October 25, 2022
Describing settings of care in the last 100 days of life for cancer decedents: a population-based descriptive studyAbe Hafid, Michelle Howard, Colleen Webber, et al.
Cancer Medicine|October 25, 2022
Identification of a novel prognostic signature correlated with epithelial-mesenchymal transition, N6-methyladenosine modification, and immune infiltration in colorectal cancerXiao Qu, Honghong Tan, Jingxian Mao, et al.
Cancer Medicine|October 25, 2022
Tumor immune microenvironment in therapy-naive esophageal adenocarcinoma could predict the nodal statusAndromachi Kotsafti, Matteo Fassan, Francesco Cavallin, et al.
Pageof 934